Disclosed is a pharmaceutical composition for treating at least one of a depression and an anxiety disorder, comprising: a ginsenoside consisting of an Rgl and an Rb 1; a glycyrrhizically related acid being one selected from a group consisting of a glycyrrhizic acid, a glycyrrhetinic acid and a combination thereof; and a jujuba cyclic adenosine monophosphate (Jujuba cAMP).